Diabetes and Thyroid
negative feedback (reversible unless from glucocorticoids)
Hormonal secretion is regulated by
Beta cells in pancreas release insulin, liver takes up glucose to make glycogen, body cells take up glucose
Describe the homeostatic mechanism for when blood sugar level rise
alpha cells in pancreas releases glucagon, liver breaks down glycogen
Describe the homeostatic mechanism for when blood sugar level drop
hyperglycemia, glucose intolerance, glucosuria, ketonemia
Characteristics of DM
Type 1 DM (T1DM, IDDM, juvenile-onset)
Which type of DM has NO circulating insulin and needs insulin replacement
Type 2 DM (T2DM, NIDDM, adult-onset)
Which type of DM has insulin resistance with relative insulin deficiency (enough to prevent DKA)
glucocorticoid, immunosuppressant, atypical antipsychotics
Which drugs can induce type 3 (non-pancreatic DM)?
Type 4 DM (gestational DM)
Which type of DM is characterized by a glucose intolerance at onset/recognition of pregnancy
osmotic diuresis (leads to polyuria, polydipsia)
Acute consequences of hyperglycemia
nephropathy, neuropathy, retinopathy, neuropathic pain, gastroparesis, skin ulcers, impaired wound healing
Chronic consequences of hyperglycemia on the microvasculature
IHD, stroke, PVD, ischemia to limb (diabetic foot), fungal infections
Chronic consequences of hyperglycemia on the macrovascular (arterial narrowing)
Acts at insulin receptors on liver (no glucogenolysis/lipolysis), activates insulin-dependent glucose transporters (increase cellular uptake)
MOA for insulin
different amino acids at specific sites (changes onset and duration)
What are the differences between the multiple forms of insulin?
Short t1/2 (3-5 min)
Why can’t insulin be given orally?
lispro, aspart, glulisine, inhaled (15-20 min)
What are the rapid forms of insulin
regular insulin
What are the short forms of insulin
NPH
What are the intermediate forms of insulin
determir, glargine
What are the long forms of insulin
short/rapid acting for after meals, long to maintain basal levels
Describe the typical insulin dosing regimen - individualized to patients
cough, decreases PFTs, lung cancer; No copd peeps
ADRs and C/I for inhaled insulin
meal carb content, blood glucose, concurrent activity
When using an infusion pump, doses of insulin are based on
beta blockers
What medication class blunts the symptoms like tachycardia, sweating, blurred vision, warmth, and trembling from hypoglycemic episodes?
too high of a dose, mismatch between Cmax and food intake, exercise, alcohol
What might cause hypoglycemia
test blood then inject insulin, then eat
What steps can be taken to avoid hypoglycemia?
confusion, drowsiness, weakness
Neurological symptoms of hypoglycemia
lipohypertrophy, lipoatrophy
What can occur at or near the injection site?
patient education, rotate site, mix insulin thoroughly, store medications properly
Ways to avoid lipohypertrophy
Use human insulin
Ways to avoid lipoatrophy
Works at beta islet cells to produce more insulin
MOA for secretagogues (sulfonylureas)
upregulate GLUT transporters (increase insulin sensitivity and uptake), decrease gluconeogenesis
MOA for glitazones
decrease gluconeogenesis
MOA for biguanides (metformin)
stimulate insulin production after eating
MOA for incretin and GLP-1 mimetics
blocks the inactivation of GLP-1 in the blood vessels
MOA for DPP-4 inhibitors
Act on the proximal tubule to decrease the amount of glucose reabsorbed
MOA for SGLT-2 inhibitors
DKA (decrease in blood glucose leads to a decrease of insulin use)
What is a major risk of using SGLT-2s (off-label) in type 1 DM?
chlorpropamide, tolazamide, tolbutamide
Tell me some 1st gen sulfonylureas
gliclazide, glimepiride, glipizide, glyburide
Tell me some 2nd gen sulfonylureas
nateglinide, repaglinide
Tell me some meglitinides
acarbose, miglitol
Tell me some alpha glucosidase inhibitors
pioglitazones, rosiglitazone
Tell me some thiazolidinediones
Exenatide, -gliptins (DPP4 inhibitors), -glutides (GLP analogs)
Which medications are incretin based?
-flozins
Tell me some SGLT-2 inhibitors
semaglutide, liraglutide, tirzepide (GLP/GIP)
Which oral hypoglycemic drugs are approved for weight loss?
decrease gastric acid secretion (slows gastric emptying), decreases food intake (GIP in brain),
MOA for tirzepatide (dual GLP-1 and GIP agonist)
NVD, Abd pain, constipation, intestinal blockages, sunken eyes, gaunt cheeks, wrinkles, muscle wasting, sarcopenia
ADRs for the ozempic girlies
hypoglycemia, GI disturbances, photosensitivity
ADRs for meglitinides and sulfonylureas
DDI, disulfram reaction with alcohol, hypoglycemia in elderly (chlorpropamide)
ADRs for 1st gen sulfonylureas
meglitinides have a rapid onset and short duration
How do meglitinides and sulfonylureas compare
weight gain, DDI
ADRs for meglitinides
pancreatitis
ADRs for Exenatide
HA, nausea
ADRs for DPP4 inhibitors
fluid retention, edema, BBW for CHF
ADRs for thiozolidindiones
HF, HTN
C/I for thiozolidindiones
diarrhea (50% of patients), lactic acidosis
ADRs for metformin
slow carb absorption in gut
MOA for alpha glucosidase inhibitors
diarrhea, flatulence
ADRs for alpha glucosidase inhibitors
Use with mealtime insulin to suppress glucagon, decrease carb absorption in gut
MOA for pramlintide (analog for pancreatic amylin)
BBW for hypoglycemia (check sugars, heart rate, etc)
ADRs for pramlintide
hypotension, dehydration, UTI, decreased bone densities
Other than DKA what are some ADRs for SGLT-2 inhibitors
metformin (that’s why it’s 1st line baby)
What oral hypoglycemic has the LOWEST potential to cause hypoglycemia
weight, blood glucose, HbA1c
When managing hyperglycemia what do we need to monitor?
glucagon, dextrose, oral sugar (if patient is conscious)
Treating hypoglycemia
Insulin, fluid, monitor K+ (insulin shoves K+ into the cell)
Treating DKA
thiazides, glucocorticoids, SGLT-2 off label
Meds with risk of DKA
liothyronine (T3), Levothyroxine (T4), liotrix (T4 & T3)
What drugs are used for the replacement therapy for hypothyroidism?
iodine, potassium iodine, methimazole (prodrug: carbimazole), PTU, radioactive iodine, beta blockers (symptom management only)
What drugs are used for the management of hyperthyroidism?
disrupts hormone synthesis (take 1+ month for effect)
MOA for radioactive iodine (131 I)
blocks organification (No T4, T3, DIT), inhibits NA/I symporter
MOA for Lugol’s solution
prevent iodide organification (No T4, T3, DIT)
MOA for thionamides
prevents peripheral conversion of T4 to T3
MOA for PTU
131 I, sub-total thyroidectomy
ablative treatments for hyperthyroidism
pregnancy, child under 12, Graves, pre-ablative therapy
Palliative treatments for hyperthyroidism are used for
Do not modify the action of the T3 and T4 that’s already there
Why do thionamides and PTU have a delayed effect
methimazole (prodrug: carbimazole)
Examples of thionamides (more potent than PTU)
PTU (watch LFTs for severe hepatitis)
Which drug that impairs thyroid hormone synthesis is preferred during the 1st trimester of pregnancy because it is less likely to cross placenta?
altered taste/smell (methimazole), rash, polyarthritis, reversible agranulocytosis (watch CBC and infection risk)
ADRs for PTU and thionamides
block uptake of iodine via the inhibition of Na/I symporter
MOA for anion inhibitors like Perchlorate and Thiocynate
thionamides, propanolol, KI, prednisolone
Treatment plan for thyroid storm
cross placenta, hypersensitivity to large amounts of iodide, reversible iodism (metallic taste, burning mouth, sore teeth)
ADRs for Lugol’s (SSKI)
propanolol, metroprolol, atenolol (NO PINDOLOL or ACEBUTOLOL)
Which beta blockers can be used for hyperthyroidism
tachycardia, HTN, arrhythmias, angina, tremor, anxiety, insomnia, heat intolerance, HA, weight loss
ADRs from too much T3 (AKA the reason liothyronine isn’t first line)
protein antigencity (rejection), variable hormone concentration, instability
Why do we avoid desiccated thyroid hormone?
Amio, corticosteroids, iodinated contrast media, IFN-alpha, tyrosine kinase inhibitors, immune checkpoint inhibitors
What medications can cause hypothyroidism
Amio, IFN-alpha, immunotherapy, lithium
What medications can cause hyperthyroidism
Insulin, pramlintide, sulfonylureas, meglitinides, GLP-1s, DPP-4 inhibitors, SGLT-2 inhibitors, thiazoliniones, metformin
Which drugs have the highest hypoglycemic risk (Highest to lowest)?